U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT07532226) titled 'A Study of Guselkumab Treatment Persistence in Psoriatic Arthritis Participants' on April 08.
Brief Summary: This observational study aims to assess the 1-year persistence of guselkumab in adult patients with psoriatic arthritis (an inflammatory disease that affects the joints in participants with psoriasis, a skin condition that causes red, scaly patches).
Study Start Date: April 13
Study Type: OBSERVATIONAL
Condition:
Arthritis, Psoriatic
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Janssen-Cilag Ltd.
Published by HT Digital Content Services with permission from Health Daily Digest....